Pain
FDA/CDC
FDA approves sufentanil for adults with acute pain
The opioid is to used for only adult patients in settings that are closely controlled.
Feature
Palliative care update highlights role of nonspecialists
The latest guideline revision aims to establish a foundation for “gold-standard” palliative care.
Conference Coverage
TENS cuts fibromyalgia pain in large RCT
CHICAGO – Women with fibromyalgia who self-administered transcutaneous electrical nerve stimulation reported greater pain reduction than controls...
From the Journals
XR-naltrexone beats oral medication for opioid use disorder
After 6 months, 57% of patients in the XR-naltrexone group were retained in treatment, compared with 28% of the oral group.
Feature
Suicide prevention in rheumatology: Engagement is key
From the Journals
Amitriptyline may be an alternative treatment for chronic low back pain
FDA/CDC
Emgality approved for migraine prevention in adults
The calcitonin gene–related peptide antagonist was tested in both episodic and chronic migraine.
Daily News Podcast
Does America have a gabapentinoid problem?
And atrial fibrillation guidelines may miss the mark with oral anticoagulation.
Latest News
House, Senate agree on broad opioid legislation
Huge bill to address the opioid epidemic contains many provisions that will affect physicians.
Conference Coverage
Signs point to growing abuse of gabapentinoids in the U.S.
LAS VEGAS – Several states have made gabapentin a Schedule V controlled substance while others have mandatory reporting of its dispensing and...
Conference Coverage
Ketamine infusions may be helpful in central sensitization pain syndromes